ArticleMedical oncology (Northwood, London, England)2022

Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis.

Baijun Dong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.